New biomarkers are being identified for emerging peptides
Janetzki points out that for an unapproved peptide not evaluated by the TGA, greater professional responsibility falls on doctors and compounding pharmacists to determine the medicines safety and efficacy
Symptoms include: The pale yellow color of the skin Red, painful tongue Pins and needles, numbness, or other strange feelings in the hands, legs, or feet Vision disturbances Having trouble walking and keeping your balance Loss of memory and sadness Differences in mood, thoughts, feelings, and behavior are easily observed Confused and unable to think
Evaluate Cold-Chain Shipping: Peptides degrade in heat
The safety profile, optimal dosing strategies, and long-term effects in humans have not been fully established